esmolol has been researched along with Brain Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyagi, T; Horiguchi, T; Nishikawa, T; Tobe, Y | 1 |
| Han, SR; Kim, JS; Ko, SB; Lee, KS; Shin, HE | 1 |
2 other study(ies) available for esmolol and Brain Infarction
| Article | Year |
|---|---|
Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male; Morpholines; Nerve Degeneration; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Treatment Outcome; Urea | 2010 |
Perioperative stroke in the brain and spinal cord following an induced hypotension.
Topics: Brain Infarction; Female; Humans; Infarction; Middle Aged; Preoperative Care; Propanolamines; Spinal Cord; Spinal Stenosis; Stroke | 2003 |